Round Rock Advisors »

Akebia Therapeutics shares owned by Round Rock Advisors

Quarter-by-quarter ownership of Akebia Therapeutics (AKBA) shares owned by Round Rock Advisors from 13F filings

Historical chart of Round Rock Advisors investment in Akebia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akebia Therapeutics held by Round Rock Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akebia Therapeutics by Round Rock Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $427k 143k 2.98

More positions owned by Round Rock Advisors

Invesco Qqq Tr Unit Ser 1 (QQQ)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Vanguard Whitehall Fds High Div Yld (VYM)
Vaneck Etf Trust Semiconductr Etf (SMH)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Index Fds Mid Cap Etf (VO)
Apple (AAPL)
Microsoft Corporation (MSFT)
Select Sector Spdr Tr Indl (XLI)
Ishares Tr Select Divid Etf (DVY)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Select Sector Spdr Tr Sbi Healthcare (XLV)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Alphabet Cap Stk Cl C (GOOG)
American Centy Etf Tr Short Durtn Strg (SDSI)

View all positions for Round Rock Advisors

Top funds holding Akebia Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Geode Capital Management
Morgan Stanley
Renaissance Technologies
UBS Group
Citadel Advisors
Qube Research & Technologies
MPM Oncology Impact Management
Millennium Management
Franklin Resources
Northern Trust
Affinity Asset Advisors
Invesco

View all funds holding Akebia Therapeutics